Abstracts tagged "rheumatoid arthritis (RA) and spine involvement"

Abstract Number: 1061 • 2014 ACR/ARHP Annual Meeting
How Does Rheumatoid Arthritis Disease Activity Affect Development of Upper Cervical Lesions? a Retrospective Study of Cervical Spine X-Rays Combined with a Cohort Study in Rheumatoid Arthritis Patients
Osamu Ishida^1,2, Katsunori Ikari³, Eisuke Inoue³, Atsuo Taniguchi⁴, Shigeki Momohara¹ and H. Yamanaka³, ¹Orthopedics, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ²Orthopedics, Kyoto City Hospital, Kyoto, Japan, ³Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ⁴Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
Background/Purpose It is believed that 40% to 80% of patients with rheumatoid arthritis (RA) have cervical spine lesions. In particular, atlantoaxial subluxation (AAS) and vertical…
Abstract Number: 401 • 2014 ACR/ARHP Annual Meeting
Association of Anti-Thyroid Autoantibodies with Fibromyalgia in Rheumatoid Arthritis
Jowairiyya Ahmad¹, Helena Blumen², Claudene George³, Asha Shrestha⁴ and Clement Tagoe⁵, ¹Geriatrics, Albert Einstein College of Medicine/Montefiore Medical Centre, Bronx, NY, ²Geriatrics, Albert Einstein College of Medicine, Bronx, NY, ³Geriatrics, Albert Einstein College of Medicine/Montefiore Medical centre, Bronx, NY, ⁴Rheumatology, Albert Einstein College of Medicine/Montefiore Medical Centre, Bronx, NY, ⁵Rheumatology, Albert Einsetin College of Medicine/Montefiore Medical Centre, Bronx, NY
Background/Purpose Autoimmune thyroiditis has been linked independently with fibromyalgia and chronic widespread pain. We studied how the presence of autoimmune thyroiditis affects the clinical presentation…
Abstract Number: 223 • 2014 ACR/ARHP Annual Meeting
Risk Factors for Clinical Vertebral Fractures in Japanese Men and Women with Rheumatoid Arthritis: Results from a Large Prospective Observational Cohort Study
Osamu Ishida¹, Takefumi Furuya², Eisuke Inoue³, Kensuke Ochi², Katsunori Ikari², Atsuo Taniguchi⁴, Hisashi Yamanaka² and Shigeki Momohara⁴, ¹Orthopedics, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ²Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ³Rheumatology, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, ⁴Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
Background/Purpose: Patients with rheumatoid arthritis (RA) are at high risk of developing vertebral fractures. Previously, utilizing data from our Institute of Rheumatology Rheumatoid Arthritis (IORRA)…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].